Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Yum! Brands, Inc. (YUM) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Yum! Brands, Inc. (YUM) - free report >>
You Can Make $100,000 Working At...Taco Bell?
Popular Mexican fast food chain Taco Bell, owned by Yum! Brands (YUM - Free Report) , is on the hunt for new restaurant managers, and is hoping that a higher salary will help attract applicants.
The chain will test a $100,000 salary in select U.S. locations in the Midwest and Northeast. In comparison, current salaries for Taco Bell general managers range from $50,000 to $80,000.
The hot U.S. labor market has been impacting fast food chains like Taco Bell for a while now, as well as Shake Shack (SHAK - Free Report) and Darden Restaurant’s (DRI - Free Report) Olive Garden. There just aren’t enough available workers to fill needed job positions. And back in November, the unemployment rate fell to 3.5% while average hourly earnings increased and beat estimates.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>